𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PCN83 Cost Effectiveness Analysis in the Veneto Region of Cabazitaxel Versus Mitoxantrone in Patients with Metastatic Hormone Refractory Prostate Cancer, Previously Treated With a Docetaxel Containing Regimen

✍ Scribed by P.R. Maran; A. Aiello; M.R. Magrì; C. Alberti; E. Visentin; F. Venturini; G. Scroccaro


Book ID
119312369
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
59 KB
Volume
15
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.